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Abstract 
Microbeam radiation therapy (MRT) is a novel irradiation technique for brain tumours treatment currently 
under development at the European Synchrotron Radiation Facility in Grenoble, France. The technique is 
based on the spatial fractionation of a highly brilliant synchrotron X-ray beam into an array of microbeams 
using a multi-slit collimator (MSC). After promising pre-clinical results, veterinary trials have recently 
commenced requiring the need for dedicated quality assurance (QA) procedures. The quality of MRT 
treatment demands reproducible and precise spatial fractionation of the incoming synchrotron beam. The 
intensity profile of the microbeams must also be quickly and quantitatively characterized prior to each 
treatment for comparison with that used for input to the dose-planning calculations. The Centre for 
Medical Radiation Physics (University of Wollongong, Australia) has developed an X-ray treatment 
monitoring system (X-Tream) which incorporates a highspatial- resolution silicon strip detector (SSD) 
specifically designed for MRT. Inair measurements of the horizontal profile of the intrinsic microbeam X-
ray field in order to determine the relative intensity of each microbeam are presented, and the alignment 
of the MSC is also assessed. The results show that the SSD is able to resolve individual microbeams 
which therefore provides invaluable QA of the horizontal field size and microbeam number and shape. 
They also demonstrate that the SSD used in the X-Tream system is very sensitive to any small 
misalignment of the MSC. In order to allow as rapid QA as possible, a fast alignment procedure of the 
SSD based on X-ray imaging with a low-intensity low-energy beam has been developed and is presented in 
this publication. 
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Michael Lercha
aCentre for Medical Radiation Physics, University of Wollongong, Australia, and bEuropean Synchrotron
Radiation Facility, France. *Correspondence e-mail: pauline.fournier.pf@gmail.com
Microbeam radiation therapy (MRT) is a novel irradiation technique for brain
tumours treatment currently under development at the European Synchrotron
Radiation Facility in Grenoble, France. The technique is based on the spatial
fractionation of a highly brilliant synchrotron X-ray beam into an array of
microbeams using a multi-slit collimator (MSC). After promising pre-clinical
results, veterinary trials have recently commenced requiring the need for
dedicated quality assurance (QA) procedures. The quality of MRT treatment
demands reproducible and precise spatial fractionation of the incoming
synchrotron beam. The intensity profile of the microbeams must also be quickly
and quantitatively characterized prior to each treatment for comparison with
that used for input to the dose-planning calculations. The Centre for Medical
Radiation Physics (University of Wollongong, Australia) has developed an
X-ray treatment monitoring system (X-Tream) which incorporates a high-
spatial-resolution silicon strip detector (SSD) specifically designed for MRT. In-
air measurements of the horizontal profile of the intrinsic microbeam X-ray field
in order to determine the relative intensity of each microbeam are presented,
and the alignment of the MSC is also assessed. The results show that the SSD is
able to resolve individual microbeams which therefore provides invaluable QA
of the horizontal field size and microbeam number and shape. They also
demonstrate that the SSD used in the X-Tream system is very sensitive to any
small misalignment of the MSC. In order to allow as rapid QA as possible, a fast
alignment procedure of the SSD based on X-ray imaging with a low-intensity
low-energy beam has been developed and is presented in this publication.
1. Introduction
Quality assurance (QA) in any radiotherapy modality is
crucial to mitigate the risk of side-effects due to accidental
over-dosage of healthy tissue, and maximize the efficacy of the
treatment by ensuring adequate dose coverage to the target.
Pre-treatment quality control (QC) is a vital link in the QA
chain (IAEA, 2000) when combined with other routine QCs
such as patient-specific independent pre-treatment dose
calculations [Monte Carlo checking of treatment planning
system (TPS) calculations] (Bush et al., 2011), in vivo dosi-
metry (Qi et al., 2011) and patient follow-up (Gehrmann
et al., 2014).
For the past decade, patient-specific pre-treatment plan
verification in conventional radiotherapy modalities such as
intensity modulated radiation therapy (IMRT) and volumetric
modulated arc therapy (VMAT) has mostly been carried out
using two-dimensional dosimetry devices (Boggula et al., 2011)
including, for small-field dosimetry, the recently introduced
high-spatial-resolution ‘MagicPlate-512’ (Aldosari et al.,
ISSN 1600-5775
# 2016 International Union of Crystallography
2014). These devices are embedded in a solid water phantom
and subject to irradiation by each treatment field. The
resulting two-dimensional dose distribution is then compared
with that predicted by the TPS following calculation of the
dose distribution in a virtual water volume. This comparison is
typically carried out using gamma analysis: a hybrid distance-
to-agreement/dose difference method (Low & Dempsey,
2003). Recently, the clinical relevance of performing such a
comparison has been questioned as there is a lack of corre-
lation between agreement of two-dimensional dose distribu-
tions measured and calculated in water and agreement
between clinically relevant parameters such as dose-volume
histograms (DVHs) in the patient anatomy (Zhen et al., 2011).
As a result, there is a move towards fluence-based pre-treat-
ment plan verification. In this revised approach, the fluence
map of the treatment field is measured, used to calculate a
three-dimensional dose distribution in a patient computed
tomography dataset, and derive clinically relevant dosimetric
quantities from DVHs (Nakaguchi et al., 2015). In this article
we investigate the feasibility of applying such an approach to
microbeam radiation therapy.
Microbeam radiation therapy (MRT) is an exciting devel-
opment in the field of radiation oncology. It involves the
treatment of tumours using planar arrays of highly collimated
low-divergent X-ray microbeams. The underlying principle of
MRT is a fascinating radiobiological effect known as the
dose-volume effect, whereby healthy tissue demonstrates a
remarkable resistance to ionizing radiation when spatial
fractionation of the primary beam into microscopic beams is
employed (Zeman et al., 1961). The fundamental cause for this
difference in response, and the optimal level of spatial frac-
tionation, is the topic of ongoing investigations (Dilmanian
et al., 2002; Serduc et al., 2008, 2009; Bouchet et al., 2010, 2013,
2014, 2015; Sprung et al., 2012; Fernandez-Palomo et al., 2013).
To date the majority of studies have been carried out at the
European Synchrotron Radiation Facility (ESRF) and have
shown the efficacy of MRT in treating gliomas in rats and mice
(Laissue et al., 1998; Régnard et al., 2008; Serduc et al., 2008;
Schültke et al., 2008; Bouchet et al., 2010, 2012). As a result,
veterinary trials are commencing at the ESRF. Currently MRT
is limited to synchrotron research facilities owing to the
requirements for low-divergence and high-intensity X-ray
sources; however, interest in hospital-based systems is growing
(Hadsell et al., 2013).
The MRT lateral dose profile consists of a succession of
peaks corresponding to the dose deposited by the microbeams.
The dose deposited in the region between two peaks origi-
nates from the scattered photons from the peaks and is called
the valley dose. The ratio between these two doses is an
important parameter and is called peak-to-valley dose ratio
(PVDR). In order to remain safe for the healthy tissue, the
spatial beam fractionation needs to be ensured and the valley
dose must remain below the organ dose tolerance (Dilmanian
et al., 2002). Moreover, the MRT treatment is delivered in one
single fraction. Consequently there is a pressing need for rapid
and effective pre-treatment QA of the intensity distribution of
MRT microbeams.
Gafchromic1 films are currently the reference dosimeters
for the peak and valley dose experimental determination in
MRT and good agreement has been obtained between
Gafchromic1 films and Monte Carlo simulations for the
determination of the PVDR (Martı́nez-Rovira et al., 2012;
Bartzsch, 2014). However, a delay between 24 and 48 h is
necessary between the film exposure and reading in order to
allow the polymerization process to stabilize (Niroomand-Rad
et al., 1998). Moreover, even films dedicated to high-doses
measurements have dose range limitations that prevent the
peak and valley dose to be read on the same film. The limited
dynamic range of the film response combined with the large
PVDRs typically utilized in MRT thus make precise dosimetry
very challenging.
The Centre for Medical Radiation Physics (CMRP) has
been working on dosimetry in MRT since 1996. MOSFET
(metal oxyde semiconductor field-effect transistor) detectors
were the first solid-state dosimetry devices investigated due to
their high spatial resolution (about 1 mm) and their ability to
give an instant readout (Rosenfeld et al., 1999; Kaplan et al.,
2000). They have been used for the measurements of peak
dose, valley dose and PVDRs at the ESRF (Bräuer-Krisch
et al., 2003; Siegbahn et al., 2009). However, the MOSFET
detectors had a low tolerance to high dose rates that
prevented them from being used under the full beam intensity
conditions under which MRT is performed. Indeed, Siegbahn
et al. (2009) observed that the MOSFET was saturated after
an accumulated absorbed dose of 1000 Gy and had to be
replaced. This composes a major limitation of the device since
dose rates as high as 20 kGy s1 can be encountered in MRT.
Moreover, it has also been stated that the interaction of the
microbeam with the different average atomic number of the
elements composing the MOSFET detector induced a lateral
distortion in the microbeam profile (Rosenfeld et al., 2005).
The CMRP thus developed a new dosimetry system for MRT
applications based on a high-resolution single strip detector
(SSD) (Lerch et al., 2011; Petasecca et al., 2012).
At the ESRF, the alignment of the multi-slit collimator
(MSC) is performed by monitoring the output of a down-
stream large-area ionization chamber (IC), covering the whole
beam, while rotating the MSC about its vertical axis. The MSC
is considered to be optimally aligned when the integrated air-
kerma measured by the IC is maximum. However, the IC is
not able to provide any information regarding the intensity
profile of the microbeams. Herein we investigate the ability of
the SSD to detect minute misalignment of the MRT MSC, and
its potential use for rapid pre-treatment quality assurance
in MRT.
2. Material and methods
2.1. ID17 MRT beamline
The ID17 MRT beamline has been described in numerous
publications, with detailed descriptions given by Martı́nez-
Rovira et al. (2012) and Cornelius et al. (2014). The beamline is
located at the ESRF, a third-generation synchrotron source,
research papers
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where high-intensity low-divergent X-rays are generated via a
wiggler insertion device. For MRT irradiations, the wiggler gap
is set to its minimum value of 24.8 mm. Several absorbers
downstream from the wiggler are used to remove the low-
energy components from the white-beam spectrum and the
MSC is included in the beam path to generate the microbeams.
The resulting spectrum corresponds to the pre-clinical beam
filtering conditions and has a mean energy of 105 keV
(Crosbie et al., 2015).
For the in-air experiment presented in this publication, two
additional beam modifiers were inserted in the beam; a
krypton gas filter (Requardt et al., 2013) and two redundant
Compton chambers (Berkvens et al., 2013). Both devices are
used in the context of the veterinary trials for patient safety
purposes. At a 24.8 mm wiggler gap, the insertion of these
additional elements shifts the mean energy from 105 to
108 keV.
In the current study, the most relevant beamline compo-
nents are the beam-defining vertical slits, horizontal slits, the
high-precision MSC and the goniometer. The horizontal slits
are oxygen-free copper blocks situated at around 29.3 m from
the source and define the horizontal limits of the beam at the
patient position. A reference lateral field size in MRT of
20 mm was used in this study. The vertical slits, located at
38.8 m from the source, comprise tungsten carbide blocks with
an aperture of 500 mm, resulting in a beam height of 520 mm at
the patient position due to beam divergence. The MSC is
positioned at 39.3 m from the source and consists of a 8 mm-
thick block of tungsten carbide inside which 50 mm-wide slits
have been created using a high-precision wire-cutting tech-
nique (Bräuer-Krisch et al., 2009). The MSC thus produces
50 mm FWHM microbeams separated by a centre-to-centre
(c-t-c) distance of 400 mm. The patient, or dosimetry phantom,
is installed on a Kappa-type goniometer (Huber, Germany)
for positioning. Owing to the limited beam height, the goni-
ometer is used to scan the patient/phantom through the MRT
field in order to cover larger tumour sizes.
2.2. Detector and readout
The SSD used in the current study is an epitaxial device
fabricated by SPA BIT (Ukraine) whose sensitive volume
(SV) consists of a single silicon microstrip. A 50 mm-thick
epitaxial substrate is grown on top of a 370 mm-thick layer of
lower resistivity (Lerch et al., 2011; Petasecca et al., 2012) and
the SV of 900 mm  10 mm is achieved via ion implanation.
Scanning electron microscopy (SEM) images of the detector
have been acquired at the ESRF in order to observe the SSD
main features and to verify their dimensions. On the SEM
image displayed in Fig. 1, one can easily distinguish the SSD
sensitive volume.
Because of the very small dimension of the SV, very high
spatial resolution dosimetry can be performed by using
detectors in the ‘edge-on’ configuration; i.e. with the normal to
the surface of the detector orthogonal to the beam direction
(see Fig. 2). Indeed, when used in this orientation, the effec-
tive spatial resolution of the detector is mostly defined by the
depletion length and, owing to the low resistivity of the silicon,
can be as low as 10–12 mm for an applied bias of 30 V
(Petasecca et al., 2012). Two orientations of the SV are avail-
able. In the edge-on configuration, the so-called ‘90’ orien-
tation has the long axis of the SV strip parallel to the beam
direction. Conversely, the so-called ‘straight’ orientation has
the long axis of the SV strip orthogonal to the beam in the
vertical direction. The different possible orientations of the
detector and of the SV are illustrated in Fig. 2.
Horizontal detector response profile measurements were
performed in air. In this situation the X-rays interacting in the
packaged silicon device lead to a photocurrent. This current
is sampled and recorded using a fast data acquisition system
as described in detail by Petasecca et al. (2012). The data
acquisition system includes a pre-amplifier module that
converts the currents from nano-Ampere to ADC (analogue
to digital converter) counts (arbitrary units). In the current
study, the pre-amplifier had a conversion factor equal to
0.543 counts nA1. The custom software RADPLOT is used
research papers
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Figure 1
SEM image of the SSD chip where the 900 mm  10 mm sensitive volume
is indicated.
Figure 2
Diagram explaining the different possible orientations of the SSD relative
to the beam (face-on or edge-on) as well as the two different possible
orientations of the sensitive volume (straight or 90).
to configure the data acquisition system, acquire data and
display the ADC counts against time profile. After careful
alignment of the device with the central axis of the synchro-
tron radiation beam, and by scanning the device in the hori-
zontal direction, one is able to measure the energy deposition
in silicon in the array of microbeams. To facilitate rapid
installation, alignment and scanning, the device was mounted
directly on the goniometer stage in an in-air configuration (see
Fig. 3). The advantage of this method is that the QA proce-
dure is fast; however, no dosimetry measurements can be
performed due to the lack of scattering material surrounding
the sensitive volume of the detector. This is the reason why all
SSD results obtained using this method are presented in terms
of ADC counts.
2.3. Rapid detector alignment using pink-beam imaging
An imaging modality known as ‘pink-beam’ imaging
(Serduc et al., 2010) was used to align the device with the beam
axis. Currently, the imaging beam is obtained by opening the
wiggler gap from 24.8 mm to 100 mm and removing the MSC
from the beam path. Under pre-clinical beam filtering condi-
tions, moving from the irradiation to imaging modality
decreases the beam intensity by 99.99% and shifts the mean
energy from the initial 105 keV to 50 keV.
The imaging system comprises a two-dimensional X-ray
detector located around 4.3 m downstream of the goniometer
stage. The detector consists of a Fast-Readout Low-Noise
CCD camera (FReLoN) developed at the ESRF (Labiche
et al., 2007). A characterization of the FReLoN camera is
given by Coan et al. (2006). The aim is to benefit from the
small pixel size (23.26 mm  23.26 mm at the sample stage) of
the FReLoN camera to image the SSD chip in order to align it
with the beam.
When switching from irradiation to imaging mode, the
beam-defining slits can be removed from the beam path
leading to a beam height of around 2 mm at the goniometer
stage. For large samples, in order to avoid the limitation of the
image dimension in the vertical direction, a vertical scan is
performed using the goniometer and images are acquired at
different vertical offsets. The acquired frames are piled up
together to obtain a complete image of the sample (Serduc
et al., 2010).
During the beam alignment procedure, the pixel of the
FReLoN camera corresponding to the central part of the
beam is defined as the central pixel. When the MSC is inserted
in the beam, the plane of the resulting X-ray microbeams is
parallel with the vertical plane of the FReLoN camera (see
Fig. 4). The MSC is aligned in the beam in order to make the
centroid of the central microbeam match with the central pixel
of the camera.
To proceed to the SSD imaging, the detector was set up on
the goniometer stage and the MSC removed from the beam
path. One frame image of the SSD was acquired by exposing
the detector for 0.1 s. On the resulting image, the vertical and
horizontal offset between the current position of the centre of
the SSD chip and the central pixel position can be quantified.
The detector was thus moved to the central position using the
goniometer vertical and horizontal motion motors. A second
image is usually acquired to verify its correct alignment.
2.4. QC of multi-slit collimator alignment
At the ID17 biomedical beamline of the ESRF, the MSC is
aligned by the monitoring of the output of a beam monitor IC
whilst rotating the MSC about the vertical axis (z) perpendi-
cular to beam direction (x). The MSC is rotated through small
angles, typically ranging from 0.1 to 0.1 in increments of
0.01. During alignment, the wiggler gap is set to a nominal
setting of 40 mm in order to minimize beam fluence and
associated ozone accumulation in the experimental hutch. In
order to benchmark SSD measurements against the IC, the
measurements with the SSD were also performed for a wiggler
gap of 40 mm. For the beam filtering conditions considered
research papers
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Figure 3
Photograph of the setup used for the in-air experiment. (1) SSD oriented
edge-on; (2) pre-amplifier module; (3) goniometer stage.
Figure 4
Image of the 20 mm  520 mm parallel array of microbeams obtained
with the FReLoN camera.
during the experiments, moving the wiggler gap from 24.8 to
40 mm led to 62% photon flux decrease and moved the mean
energy from 108 to 90 keV.
We used here a SSD with a straight orientation of the SV
and the detector was oriented edge-on. The straight orienta-
tion of the SV was chosen to minimize the misalignment of the
SV with the microbeams. The MSC rotation angle was moved
between 0.05 and 0.05. For each angle, the SSD was
horizontally scanned through the 2 cm large array of
microbeams at a constant speed (2 mm s1). As the
measurements were performed in air, the notion of PVDR is
irrelevant in the context of the present study. We thus intro-
duced the notion of peak-to-valley intensity ratio (PVIR)
corresponding to the peak signal divided by the valley signal
measured by the SSD. The effect of the MSC rotation on the
peak and valley signal, PVIR and shape of the microbeams
was investigated.
3. Results
3.1. Rapid detector alignment with pink-beam imaging
The images acquired during the alignment process for both
face-on and edge-on detector orientations are displayed in
Fig. 5. These images consist of one single frame acquisition
(i.e. the SSD was not moved through the beam during the
image acquisition, only one image was acquired at a given
vertical position of the detector).
The pink-beam imaging of the detector is very fast as a 0.1 s
exposure per frame was sufficient to acquire the image of the
detector with a satisfying image quality. Therefore, the total
time to set up the detector and align it in the centre of the
beam was approximately 30 min.
In clinical practice a pre-aligned SSD could be mounted
permanently in air. The imaging procedure would thus merely
confirm that no misaligment of the detector, with respect to
the microbeams, had occurred immediately prior to exposing
the SSD to the full intensity X-ray microbeams to characterize
the intrinsic MRT field profile.
The red area on the image represents the height of the MRT
beam used for the experiment (i.e. 520 mm high at the goni-
ometer stage). One can notice that only a part of the detector
was exposed by the beam as the sensitive volume of the SSD
(900 mm) is longer than the beam height.
3.2. QC of the multi-slit collimator alignment
The RADPLOT software records the ADC counts as a
function of time. Knowing the scan speed of the motor used to
perform the acquisition of the microbeams horizontal profile,
we are able to convert the time variable into a distance value.
The detector response profile of a 2 cm-wide array of X-ray
microbeams obtained for a 0 angle of the MSC is displayed in
Fig. 6. In this figure, the RADPLOT data have been averaged
by a factor equal to 500 and the baseline signal has been
subtracted. During the experiment, the baseline noise of
X-Tream with the SSD was better than1.3 ADC counts (one
standard deviation) with no averaging applied. In Fig. 6 we can
verify the dimension of the lateral field size and that all 49
microbeams are correctly present. The peak and valley signals
are also presented on this figure by red and blue crosses,
respectively. The peak signal is defined as the maximum signal
in the microbeam.
Fig. 7 presents a focus on the five central microbeams of the
array presented in Fig. 6. As a logarithm
scale is used on the ordinate axis, one
can notice that the valley is not stable
and the lowest value is not necessary
in the middle of two consecutive
microbeams. Therefore, in order to
determine the valley signal, the signal
has been averaged over a region of
interest of 100 mm centred in the middle
of two consecutive microbeams. The
resulting valley is presented by the blue
crosses in Fig. 7.
Fig. 8 represents the central
microbeam profile obtained for 0.0,
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Figure 5
Images of the detector chip acquired with the FReLoN camera, in (a) face-on and (b) egde-on
orientation, with one single frame and 0.1 s exposure. The red area on the image represents the
dimensions of the MRT beam used for the experiment (i.e. 520 mm high at the goniometer stage).
Figure 6
A 2 cm-wide array of microbeams acquired in air with the SSD (after
substraction of the baseline) for a wiggler gap of 40 mm. MSC rotation
angle = 0.
0.02 and 0.04 rotation angle of the MSC about the z-axis.
One can see that the intensity of the central microbeam is
decreasing with the MSC angle because of the reduced aper-
ture resulting from the MSC misalignment.
With the change of the MSC rotation angle, one would
expect the full width at half-maximum (FWHM) of the central
microbeam to decrease as the effective slit aperture is
decreasing. Consequently, one possible way to check the MSC
alignment would be to measure the FWHM of the central
microbeam for the different angles of rotation investigated.
The highest FWHM should then be obtained for a rotation
angle corresponding to the optimum alignment of the MSC.
For the different angles of rotation investigated, the lateral
profile of the central microbeam has thus been fitted with a
Gaussian (not shown here) in order to extract the FWHM and
FW10%M (full width at 10%-maximum) values from the
fitting equation. The resulting FWHM and FW10%M values
are reported in Fig. 9. Only a 1.6% decrease is observed
between the highest and lowest FWHM and FW10%M values
which highlights the advantage of rather using an intensity
method to determine the optimum MSC rotation angle.
At the ESRF, the readings from a monitoring IC are used
for MSC alignment purposes by acquiring the IC signal while
rotating the MSC. The maximum integrated air kerma
(proportional to the total fluence) measured by the IC is
considered to correspond to the optimum MSC alignment with
the beam. However, no information about the intensity of
each microbeam can be obtained from the IC. From the
horizontal profiles obtained in-air with the SSD, the integrated
counts over the resulting microbeam arrays have been
extracted for each MSC rotation angle investigated. Fig. 10
compares the monitoring IC signal recorded for MSC rotation
research papers
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Figure 8
Central microbeam signal for three different rotation angles of the MSC
(0, 0.02 and 0.04).
Figure 9
FWHM and FW10%M of the central microbeam as a function of the
MSC angle. Only a 1.6% decrease is observed between the highest and
lowest FWHM and FW10%M values.
Figure 7
Focus on the five central microbeams of the 2 cm-wide array of
microbeams acquired in air with the SSD for a wiggler gap of 40 mm.
MSC rotation angle = 0.
Figure 10
Total silicon SSD counts integrated over the microbeam array for the
different angles investigated and comparison with the results obtained by
the beam-monitoring IC.
angles ranging from 0.1 to 0.1 with the integrated count
values extracted from the SSD measurements. Each set of data
is normalized to 1 for their respective maximum recorded
value. A good correlation can be established between the two
detectors as they both agree on a maximum signal reached
for 0.
From Fig. 9 one can see that, for a 0.0 rotation of the MSC,
the FWHM of the central microbeams is around 78 mm. At the
goniometer stage, the microbeam FWHM is expected to be
equal to 51.5 mm due to the beam divergence. The over-esti-
mation of the microbeam width is due to misalignment of the
SV of the detector. Indeed, the SV length should be parallel to
the microbeams but, as one can see in Fig. 5(b), the SSD chip is
slightly tilted in the vertical direction (7) which degrades
the effective spatial resolution.
A lateral profile containing 49 microbeams has been
acquired with the SSD fixed at 2 cm depth in a phantom made
of water equivalent material. For these measurements, the
krypton gas filter and the two redundant Compton chambers
were kept out of the beam leading to an increase of 25% of the
beam intensity compared with the previous experiments. The
wiggler gap was set to 40 mm. The three central microbeams of
the resulting array are displayed in Fig. 11 and the central
microbeam is fitted with a Gaussian. As the SSD was rigidly
mounted in the edge-on orientation in the phantom, it was
thus less sensitive to motion and its alignment could be
performed with a higher accuracy. Indeed Fig. 12 shows the
pink-beam image acquired during the SSD alignment within
the water equivalent phantom and one can clearly notice that
the tilt of the SSD chip (3) has been reduced compared
with the in-air configuration. The spatial resolution has thus
been improved accordingly: in Fig. 11 the FWHM of the
central microbeam, deduced from the Gaussian fitting equa-
tion, is equal to 61 mm. It should be noted that all FWHM
values reported in this study include the intrinsic dimensions
of the SSD.
Concerning the c-t-c distance, a value of 412  2 mm was
measured in the water equivalent phantom and 413  2 mm
in air. These values are in close agreement with the 412.2 
3.2 mm c-t-c distance reported by Bräuer-Krisch et al. (2009)
from Gafchromic1 films measurements and with the 412.2 mm
expected value at the goniometer stage due to the beam
divergence.
3.3. Effect of the MSC rotation angle on the intensity
distribution of microbeams
When performing measurements for the QA of the MSC
alignment, we observed satellite peaks on the edge of the
array of microbeams for small rotation angles of the MSC.
Fig. 13 compares the SSD response profile on the field edges
for three different angles: 0.0, 0.02 and 0.04. Satellite
peaks are only present on the right-hand edge of the array of
microbeams when the MSC is misaligned. Conversely, for
positive angles of rotation of the MSC, satellite peaks only
appear on the left-hand edge of the array of microbeams (see
research papers
J. Synchrotron Rad. (2016). 23 Pauline Fournier et al.  X-Tream QA in Synchrotron X-ray MRT 7 of 11
Figure 11
Central microbeams signal obtained at 2 cm depth in a water equivalent
phantom. The krypton gas filter and the two redundant Compton
chambers were out of the beam. The wiggler gap was set to 40 mm.
Figure 12
Image of the SSD rigidly fixed in the edge-on orientation within a water
equivalent phantom acquired with the FReLoN camera. The red area in
the image represents the dimensions of the MRT beam used for the
experiments (i.e. 20 mm  520 mm at the goniometer stage).
Figure 13
Left (a) and right (b) edges of the microbeams array profile for 0,0.02
and 0.04 rotation angles of the MSC. For negative rotation angles of
the MSC, satellite peaks appear on the right edge of the array of
microbeams.
Fig. 14). As the satellite peaks are only observed on one side
of the array and as this side is dependent on the direction of
rotation of the MSC, they are likely to be related to total
external reflection of the photons on the side walls of the
MSC. This represents an important finding, as the detection of
satellite peaks suggests a dose deposition outside of the irra-
diation field and must be minimized.
As we observed the effect of the misalignment of the MSC
on the edges of the microbeams array, Fig. 15 shows the effect
induced on the central microbeams for the following MSC
rotation angle:0.02, 0 and 0.02. One can see that the MSC
rotation angle has a strong influence on the valley signal. Once
again, photon reflections may occur on the side walls of the
MSC and modify the valley dose.
Fig. 16 displays the average of the 48 peaks and 48 valley
signals measured over the array of microbeams as a function
of the MSC angle. The uncertainty bars represent the standard
















where N is the number of peaks or valleys measured in one
array of microbeams (48 in the present case) and x is either the
peak or valley mean value over the array of microbeams. The
valley signal first increases with rotation angle of the MSC,
from 15 counts at 0 to around 17 counts at 0.02. For larger
angles, the signal in the valley decreases due to the higher
effective thickness of the MSC with misalignment thus
attenuating even more the primary beam. For the peaks, the
signal decreases constantly with the MSC angle as previously
observed in Fig. 8.
As measurements were performed in air, the SSD should
ideally only be sensitive to the photon flux. At the centre of
the microbeam the flux is not expected to change significantly
for such small MRT collimator angles since the air-scatter
contribution to the photon flux here is negligible. The
immediate decrease in response to angle demonstrates that
the SSD is sampling the intensity across a significant propor-
tion of the width of the microbeam. This result is consistent
with the SSD effective spatial resolution degradation observed
when the SSD is misaligned.
The 48 PVIR values deduced from the peak and valley
signals measurements over the microbeam array have been
averaged and are presented in Fig. 17 as a function of the MSC
rotation angle. The error bars represent the standard deviation
of the mean. For rotation angles between 0 and 0.02, the
PVIR decreases as the peak signal is decreasing while the
valley signal is increasing. For larger angles, the PVIR
increases again as the valley signal decreases at a higher rate
than the peak signal.
The QA results presented here highlight the importance of
precise alignment of the MSC relative to the X-ray beam.
Even in what may be considered a worst-case scenario for the
research papers
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Figure 14
Left (a) and right (b) edges of the microbeams array profile for 0, 0.02
and 0.04 rotation angles of the MSC. For positive rotation angles of the
MSC, satellite peaks appear on the left edge on the array of microbeams.
Figure 15
Central microbeams obtained for three different rotation angles of the
MSC (0.02, 0 and 0.02).
Figure 16
Average peak and valley signals obtained for the full range of angles
investigated.
SSD (poorly aligned), the system is still able to confirm that
the MSC is aligned appropriately. However, in order to
precisely determine the relative peak intensity of each
microbeam for input into the dose-planning system the SSD
should be optimally aligned.
4. Discussion
A single silicon-based strip detector was used for the acqui-
sition of one-dimensional profiles in air of the synchrotron
beam used in MRT. The SSD was used to measure the hori-
zontal profiles of a 2 cm-wide microbeam array. The detector
was able to detect small misalignments of the MSC which
resulted in changes in the valley shape but also in modifica-
tions of the peak, valley and PVIR values. The rotation of the
MSC did not have a significant impact on the FWHM and
FW10%M values extracted from the Gaussian fit of the
central microbeam of the array under the measurements
conditions presently used. The significance may increase if the
detector had a spatial resolution of 1 mm and was perfectly
aligned with the X-ray microbeams. Such a detector is under
development and will therefore be investigated in the future.
Consequently, the MSC alignment was performed by calcu-
lating the integrated counts recorded over the array of
microbeams by the SSD for the different rotation angles of the
MSC. The results were in agreement with the monitoring IC
currently used for the MSC alignment on ID17.
The SSD provided a complete view of the microbeam array
enabling rapid verification of the lateral field size as well as the
correct shape and number of microbeams. As the alignment
of such a small device can be tedious, we have developed
an alignment procedure based on the pink-beam imaging
modality available at the ESRF, allowing an alignment of the
SSD within half an hour for a completely dismantled SSD.
Using the SSD, satellite peaks have been detected outside
of the defined irradiation field for a misalignment angle of the
MSC as small as 0.02. The presence of such peaks suggests
that additional energy depositions could occur in the regions
between the microbeams, and this will be the subject of a
separate dosimetry investigation in the future. These satellite
peaks originate from photons that have undergone total
external reflection from the inner surface of the MSC. Future
Monte Carlo studies interfaced with a ray-tracing and X-ray
optics code (Cornelius et al., 2014) should be conducted in
order to validate this hypothesis. If this is the case, one way to
alleviate this problem would be to adapt the MSC aperture to
the beam divergence in order to have an angle of incidence
greater than the critical angle to prevent total external
reflection from occurring. Pre-treatment QA using the SSD
could thus be performed to ensure that the MSC is accurately
aligned and that the treatment beam profile is clear of any
satellite peaks.
The scattering of photons into the valley regions between
two microbeams is very sensitive to any changes in the irra-
diation set-up, in particular to the alignment of the MSC. Such
scattering should be avoided if possible or at least well char-
acterized as the scattered photons will lead to an increase in
the valley dose which could compromise the sparing of the
normal tissue. Dedicated measurements to ensure patient
safety should therefore additionally be performed with the
SSD in the future.
On the horizontal scan of the 2 cm-wide microbeam array
acquired, the measured c-t-c distance was in very good
agreement with the values previously reported by Bräuer-
Krisch et al. (2009). However, an over-estimation of the
microbeam width was observed and attributed to a slight
misalignment of the detector.
Indeed, the greatest limitation highlighted in this study is
the degradation of spatial resolution when the SV is not
perfectly aligned with the beam axis. The angular misalign-
ment of the detector could be mitigated using an additional
positioning motor available on the goniometer. However,
using such motors requires the SSD to be precisely positioned
at the centre of rotation of the goniometer coordinate frame
of reference. Adding the alignment of the SSD on the rotation
axis of the goniometer as a step within the detector set-up
would lead to a much more time-consuming task. A decrease
in the SV length could be considered to mitigate for the
detector sensitivity to slight misalignments. However, the
dimensions of the SSD must be designed in such a way so as to
ensure that an adequate photocurrent is able to be generated
in all MRT dosimetry and QA conditions (microbeam peak
and valley regions, beam filtering, depth in water or water
equivalent materials etc.). In addition, for ideal QA
measurements one needs to minimize any partial volume
effects related to the sensitive volume. Therefore a trade-off
exists between SSD sensitivity and spatial resolution. A
permanently mounted SSD in air, pre-aligned with the MRT
beam, would consequently be the most suitable alternative.
This solution will mean that the alignment will only need to be
checked. In the future, it could be envisaged to perform a one-
dimensional scan of the beam using a high-resolution one-
dimensional array of silicon microstrip detectors which could
provide an instantaneous one-dimensional fluence profile
(Povoli et al., 2015). Another possible technical improvement
research papers
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Figure 17
Average PVIRs obtained for the full range of angles investigated.
would be to include a modality within the RADPLOT soft-
ware taking the motor scanning speed as an input and thus
allowing the SSD signal to be displayed as a function of the
distance. This would considerably facilitate and accelerate
MRT QA procedures performed using the X-Tream system.
In the future, if the SSD is to be used as dosimeter in a
clinical context, the SSD would be considered as single-use
or disposable dosimeter and QA measurements could be
performed within a water or solid water phantom. The SSD
readings will have to be converted into absorbed dose values
by calibrating the SSD using an ionization chamber under
MRT reference dosimetry conditions as described by Bräuer-
Krisch et al. (2015). For purely scientific studies and pre-clin-
ical measurements, we will need to evaluate the SSD radiation
lifetime by investigating the change in SSD response with total
accumulated dose. This will be part of the standard scientific
research operating procedures in order to ensure accurate and
reproducible results from the SSD.
5. Conclusion
MRT represents important challenges in QA because of the
strong influence in biological outcome from possible mis-
alignment directly influencing the quality of the microbeams.
QA in radiotherapy is required to ensure effective treatment
and patient safety and an interest is rising in conventional
radiotherapy to pursue fluence-based pre-treatment plan
verification over in-phantom dosimetry measurements
(Boggula et al., 2010). The SSD, or similar technology, could
be a potential candidate in the field of MRT to ensure that
fluence profiles assumed by the TPS are consistent with
response profiles experimentally acquired. Finally, one can
consider extending the SSD use to MRT pre-clinical experi-
ments where an accurate knowledge of the beam properties
would contribute to reduce experimental uncertainties
between two sets of experiments. Future work will concentrate
on utilizing the SSD in a dosimetry study performed in a solid
water phantom to investigate how the satellite peaks observed
in this work translate into MRT dose profile measurements
and the impact on the corresponding peak and valley dose.
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M., Bräuer-Krisch, E., Rosenfeld, A. & Lerch, M. (2014). J.
Synchrotron Rad. 21, 518–528.
Crosbie, J. C., Fournier, P., Bartzsch, S., Donzelli, M., Cornelius, I.,
Stevenson, A. W., Requardt, H. & Bräuer-Krisch, E. (2015). J.
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Fournier, P., Hansen, T.-E., Kok, A., Lerch, M., Monakhov, E.,
Morse, J., Petasecca, M., Requardt, H., Rosenfeld, A. B., Röhrich,
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